TickerFactsScreenerDevelopers

Prelude Therapeutics Inc (PRLD) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2019: $18.88M2020: $218.31M2021: $31.83M2022: $30.61M2023: $25.29M2024: $12.47M2025: $35.26M$35.26M
2019Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$35.26M+182.6%
2024$12.47M-50.7%
2023$25.29M-17.4%
2022$30.61M-3.8%
2021$31.83M-85.4%
2020$218.31M+1056.4%
2019$18.88M—